188 related articles for article (PubMed ID: 11243885)
21. cDNA cloning of a novel CYP3A from rat brain.
Wang H; Kawashima H; Strobel HW
Biochem Biophys Res Commun; 1996 Apr; 221(1):157-62. PubMed ID: 8660328
[TBL] [Abstract][Full Text] [Related]
22. cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats.
Kirita S; Matsubara T
Arch Biochem Biophys; 1993 Dec; 307(2):253-8. PubMed ID: 8274011
[TBL] [Abstract][Full Text] [Related]
23. Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4.
Neff JA; Moody DE
Biochem Biophys Res Commun; 2001 Jun; 284(3):751-6. PubMed ID: 11396966
[TBL] [Abstract][Full Text] [Related]
24. Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation.
Zhang H; LeCulyse E; Liu L; Hu M; Matoney L; Zhu W; Yan B
Arch Biochem Biophys; 1999 Aug; 368(1):14-22. PubMed ID: 10415106
[TBL] [Abstract][Full Text] [Related]
25. cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine.
Hashizume T; Imaoka S; Hiroi T; Terauchi Y; Fujii T; Miyazaki H; Kamataki T; Funae Y
Biochem Biophys Res Commun; 2001 Feb; 280(4):1135-41. PubMed ID: 11162645
[TBL] [Abstract][Full Text] [Related]
26. Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.
Krusekopf S; Roots I; Kleeberg U
Eur J Pharmacol; 2003 Apr; 466(1-2):7-12. PubMed ID: 12679136
[TBL] [Abstract][Full Text] [Related]
27. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
Ohmori S; Nakasa H; Asanome K; Kurose Y; Ishii I; Hosokawa M; Kitada M
Biochim Biophys Acta; 1998 May; 1380(3):297-304. PubMed ID: 9555064
[TBL] [Abstract][Full Text] [Related]
28. cDNA cloning and expression of a novel CYP3A from the Syrian hamster, CYP3A31.
Alabouch S; Kurose K; Tohkin M; Bani MH; Fukuhara M; Nagata K; Yamazoe Y
Biochim Biophys Acta; 1998 Apr; 1397(1):9-13. PubMed ID: 9545515
[TBL] [Abstract][Full Text] [Related]
29. Isolation, heterologous expression and functional characterization of a novel cytochrome P450 3A enzyme from a canine liver cDNA library.
Fraser DJ; Feyereisen R; Harlow GR; Halpert JR
J Pharmacol Exp Ther; 1997 Dec; 283(3):1425-32. PubMed ID: 9400018
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
[TBL] [Abstract][Full Text] [Related]
31. Significance of the minor cytochrome P450 3A isoforms.
Daly AK
Clin Pharmacokinet; 2006; 45(1):13-31. PubMed ID: 16430309
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.
Westlind-Johnsson A; Malmebo S; Johansson A; Otter C; Andersson TB; Johansson I; Edwards RJ; Boobis AR; Ingelman-Sundberg M
Drug Metab Dispos; 2003 Jun; 31(6):755-61. PubMed ID: 12756208
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
[TBL] [Abstract][Full Text] [Related]
34. A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver.
Itoh S; Satoh M; Abe Y; Hashimoto H; Yanagimoto T; Kamataki T
Eur J Biochem; 1994 Dec; 226(3):877-82. PubMed ID: 7813478
[TBL] [Abstract][Full Text] [Related]
35. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily.
Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T
Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091
[TBL] [Abstract][Full Text] [Related]
36. Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals.
Sérée E; Villard PH; Hevér A; Guigal N; Puyoou F; Charvet B; Point-Scomma H; Lechevalier E; Lacarelle B; Barra Y
Biochem Biophys Res Commun; 1998 Nov; 252(2):392-5. PubMed ID: 9826540
[TBL] [Abstract][Full Text] [Related]
37. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Su T; Bao Z; Zhang QY; Smith TJ; Hong JY; Ding X
Cancer Res; 2000 Sep; 60(18):5074-9. PubMed ID: 11016631
[TBL] [Abstract][Full Text] [Related]
38. High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation.
Ding S; Yao D; Burchell B; Wolf CR; Friedberg T
Arch Biochem Biophys; 1997 Dec; 348(2):403-10. PubMed ID: 9434754
[TBL] [Abstract][Full Text] [Related]
39. Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.
Cotreau MM; von Moltke LL; Harmatz JS; Greenblatt DJ
Pharmacology; 2001; 63(4):210-9. PubMed ID: 11729359
[TBL] [Abstract][Full Text] [Related]
40. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.
Koch I; Weil R; Wolbold R; Brockmöller J; Hustert E; Burk O; Nuessler A; Neuhaus P; Eichelbaum M; Zanger U; Wojnowski L
Drug Metab Dispos; 2002 Oct; 30(10):1108-14. PubMed ID: 12228187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]